---
layout: page
title: "Eric DeJesus Featured by ARCS Foundation and ARCS Forward"
date: "2025-06-14"
categories:
  - press-release
  - media
  - recognition
tags:
  - ARCS Foundation
  - ARCS Forward
  - cancer research
  - Annate Bitherapeutics
header: no
image:
  title: arcs-forward-video.png
  caption: "Eric DeJesus, PhD, Annate Bitherapeutics CEO, highlighted by ARCS Foundation."
  caption_url: https://www.arcsfoundation.org/news/arcs-scholar-alum-eric-dejesus-pushes-boundaries-cancer-treatment
teaser: "The ARCS Foundation has recognized Eric DeJesus, PhD, both in a feature article and through his June 2025 ARCS Forward talk on reducing the impact of cancer."
---

The ARCS Foundation recently spotlighted **Eric DeJesus, PhD**, Founder & CEO of Annate Bitherapeutics, for his groundbreaking work in cancer immunotherapy. As an ARCS Scholar Alum, Dr. DeJesus has built on his academic foundation to launch Annateâ€™s therapeutic platform, which leverages innate immunity to fight multiple myeloma and pancreatic cancer. <!--more-->

### ðŸŽ¥ Watch the Talk  
Dr. DeJesus presented at the **June 2025 ARCS Forward event**, delivering a talk titled *Reducing the Impact of Cancer*. In this presentation, he outlines the scientific basis of Annateâ€™s therapies and the companyâ€™s vision for addressing unmet needs in oncology.  

[![Watch on YouTube](https://img.youtube.com/vi/zOhNILCmZ-s/0.jpg)](https://www.youtube.com/watch?v=zOhNILCmZ-s)

*(Click image to watch the video on YouTube)*

### ðŸ“– Read the Feature  
Alongside the event, ARCS published a feature article on Dr. DeJesus, highlighting his journey from ARCS Scholar to biotech entrepreneur:  
[ARCS Scholar Alum Eric DeJesus Pushes Boundaries in Cancer Treatment](https://www.arcsfoundation.org/news/arcs-scholar-alum-eric-dejesus-pushes-boundaries-cancer-treatment)

---

Together, the feature article and the ARCS Forward talk showcase how Annate Bitherapeutics is translating innovative research into a new generation of cancer treatments.
